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A B S T R A C T
There is a complex, bidirectional interdependence between sex steroid hormones and epilepsy;
hormones affect seizures, while seizures affect hormones thereby disturbing reproductive endocrine
function.
Both female and male sex steroid hormones inﬂuence brain excitability. For the female sex steroid
hormones, progesterone and its metabolites are anticonvulsant, while estrogens are mainly
proconvulsant. The monthly ﬂuctuations in hormone levels of estrogen and progesterone are the basis
for catamenial epilepsy described elsewhere in this issue. Androgens are mainly anticonvulsant, but the
effects are more varied, probably because of its metabolism to, among others, estradiol.
The mechanisms for the effects of sex steroid hormones on brain excitability are related to both
classical, intracellularly mediated effects, and non-classical membrane effects due to binding to
membrane receptors. The latter are considered the most important in relation to epilepsy. The different
sex steroids can also be further metabolized within the brain to different neurosteroids, which are even
more potent with regard to their effect on excitability. Estrogens potentiate glutamate responses,
primarily by potentiating NMDA receptor activity, but also by affecting GABA-ergic mechanisms and
altering brain morphology by increasing dendritic spine density. Progesterone and its main metabolite
5a-pregnan-3a-ol-20-one (3a-5a-THP) act mainly to enhance postsynaptic GABA-ergic activity, while
androgens enhance GABA-activated currents.
Seizures and epileptic discharges also affect sex steroid hormones. There are close anatomical
connections between the temporolimbic system and the hypothalamus controlling the endocrine
system. Several studies have shown that epileptic activity, especially mediated through the amygdala,
alters reproductive function, including reduced ovarian cyclicity in females and altered sex steroid
hormone levels in both genders. Furthermore, there is an asymmetric activation of the hypothalamus
with unilateral amygdala seizures. This may, again, be the basis for the occurrence of different
reproductive endocrine disorders described for patients with left-sided or right-sided temporal lobe
epilepsy.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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There is a complex interaction between hormones and epilepsy
that is manifest in many different ways. Firstly, hormones
inﬂuence epilepsy, while secondly, epilepsy affects hormones. In
addition, antiepileptic drugs (AEDs) can interact both with the
epilepsy itself and with hormones. The focus of this review is
hormones and gender, addressing the interactions between
epilepsy and sex steroid hormones. Interactions with AEDs are* Corresponding author at: Department of Neurology, Oslo University Hospital –
Rikshospitalet, PO Box 4950, Nydalen, 0424 Oslo, Norway. Tel.: +47 23072762.
E-mail address: erik.tauboll@medisin.uio.no (E. Taubøll).
http://dx.doi.org/10.1016/j.seizure.2015.02.012
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights redescribed elsewhere in this issue of Seizure, which is a special issue
based on presentations held at the Second Gender Issues in
Epilepsy Meeting in Oslo, 28–29 August 2014.
The male and female peripheral sex steroid hormones,
estradiol, progesterone, and testosterone, are all derived from
cholesterol and are closely linked as seen in Fig. 1. Cholesterol,
having been metabolized to progesterone, can be further metabo-
lized to androstenedione and testosterone. These, in turn, through
aromatization can be transformed to estradiol. Furthermore,
progesterone is metabolized through the action of the enzymes
5a-reductase and 3a-hydroxysteroid to 3a-5a-THP, a very
powerful antiepileptogenic substance. Steroids that are synthe-
sized in the brain are also called neurosteroids; they are precursors
and metabolites of steroid hormones inﬂuencing neuronalserved.
Fig. 1. Formation of progesterone and its metabolites, estrogens, and testosterone from cholesterol.
Published with permission from: Frye CA, Rhodes ME. Female sex steroids and neuronal excitability. In: Schwartzkroin PA, editor. Encyclopedia of basic epilepsy research. UK:
Academic Press/Elsevier; 2009, p. 477–84.
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enzymes 5a-reductase and 3a -hydroxysteroid, the most impor-
tant enzymes enabling the brain to produce neurosteroids, are
widely distributed in the brain.
Clinically, the effect of hormones on brain excitability appear as
ﬂuctuations in seizure frequency in relation to changes in hormone
levels. This is most typically seen in catamenial epilepsy [1,2],
where seizure frequency varies with ﬂuctuations in estrogen and
progesterone levels (Fig. 2). The phenomenon of cyclical changes in
seizure frequency in relation to menstruation was ﬁrst properly
studied by Gowers [3] in 1885, who found a relationship between
menstrual phases and seizure frequency in 46 of 82 patients. This
ﬁnding was later conﬁrmed in numerous studies, like that of
Laidlaw [4] who monitored 50 institutionalized patients anddemonstrated seizure exacerbation in relation to menstruation in
72% of the women. The phenomenon of catamenial epilepsy
demonstrates the clinical relevance of hormonal effects on brain
excitability.
2. The effect of hormones on epilepsy
Female sex steroid hormones have repeatedly been shown to
affect neuronal excitability, with estrogens being mainly
proconvulsant and progesterone and its metabolites being
anticonvulsant.
Clinically, a direct excitatory effect of estrogen was convinc-
ingly demonstrated by Logothetis et al. in 1959 [5]. Intravenous
(i.v.) injections of the estrogenic substance, Premarin, were
Fig. 2. Cross-correlogram between menstrual status and seizure occurrence in a
patient with catamenial epilepsy. Note the marked, local positive peaks occurring
every 4 weeks, indicating a high incidence of co-occurrence of seizures and
menstruation.
Published with permission from: Taubøll E, Lundervold A, Gjerstad L. Temporal
distribution of seizures in epilepsy. Epilepsy Res 1991;8:153–65.
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patients showed increased epileptogenic activity and four experi-
enced frank seizures (Fig. 3). Of the four patients that received the
highest dose, three patients experienced ﬁts, indicating a dose-
dependent effect of estrogen on seizure excitability. In contrast to
estrogen, progesterone infusions in epilepsy patients reduce
seizure susceptibility. Ba¨ckstro¨m et al. [6] studied seven female
patients with partial epilepsy who received a 2-h i.v. infusion of
progesterone during the ﬁrst week of their menstrual cycles. The
progesterone infusions reached plasma concentrations during the
luteal phase. Four of the patients showed signiﬁcant decreases in
spike frequency during the infusion, with a latency of 1–2 h. The
two patients demonstrating the most pronounced effect showed
the lowest progesterone binding capacity, while the patients not
showing any effect had the highest binding capacity. Thus, the
effect seems to be related to the concentrations of free hormone.
Similar clinical human studies as described for progesterone and
estradiol have not been performed with testosterone.
The results from these clinical studies have been supported by
several animal studies that have demonstrated increased seizure
frequency after estrogen administration, and decreased seizure
frequency after progesterone injections. Estrogen administered asFig. 3. EEG in a patient with epilepsy during estrogen (Premarin) injection leading to s
Published with permission from: Logothetis J, Harner R, Morrell F, Torres F. The role oinjections [5] or applied directly to the cortex [7] has potent
epileptogenic effects, and topical application of estrogen has even
been used as a model of focal epilepsy (see Prince [8]). Estradiol
also reduces electroshock threshold, increases paroxysmal spiking
in epileptogenic foci in cats and rabbits, facilitates kindling, and
potentiates seizures induced by different chemoconvulsants [9].
Progesterone and its metabolites have been shown to increase
electroshock threshold [10], protect against audiogenic and
pentylenetetrazol (PTZ)-induced seizures, inhibit kindling, and
protect against electroshock-induced seizures [9].
Androgens seem to have more varied effects, although a
generally antiseizure effect has been demonstrated [11]. Adminis-
tration of androgens directly to the hippocampus of castrated rats
reduces PTZ-induced seizures, and testosterone increases the
electroconvulsive threshold in males at low doses, and in both
sexes at higher doses [12].
3. Mechanisms for the effects of estrogens
There are three biologically active estrogens, as seen in Fig. 1.
Estradiol is the main estrogen in fertile women and has been
studied the most. Estriol is the major estrogen in pregnancy, while
estrone is most abundant in postmenopausal women.
Mechanisms involved in the excitatory effect of estrogens are
complex, and in some circumstances estrogens may even be
anticonvulsant. Estrogens, as the other peripheral sex steroid
hormones, exert their effects via intracellular receptors, the
estrogen receptors ERa and ERb, of which the effect of the latter
is the most important for the non-reproductive effects of the
hormone. Some experiments have found that low estrogen doses
may actually reduce seizures by acting at ERb [13], and long-term
estrogen exposure may decrease susceptibility to kainate-induced
seizures [14].
In general, however, the effect of estrogens should be
considered excitatory. Important for the generally excitatory
effect, is the ability of neurons to respond rapidly to the excitatory
effect of glutamate [15–17]. This potentiating effect is thought to
inﬂuence primarily N-methyl-D-aspartate (NMDA), but also non-
NMDA types of glutamate receptors [17]. First, it was shown that
estradiol increased neuronal responsiveness to locally applied
excitatory amino acids in the cerebellum [15,16]. Using extracel-
lular recordings from single Purkinje cells in rat cerebellum,
systemic injections of estradiol produced a marked enhancement
of the excitatory response to iontophoretically applied glutamate.
The effect was dose-dependent. Very similar results were obtained
with local application. Typically, enhancement of glutamateeizure.
f estrogens in catamenial exacerbation of epilepsy. Neurology 1959;9:352–60.
E. Taubøll et al. / Seizure 28 (2015) 3–116excitation was noted within 40 s after onset of local steroid
application.
GABA-ergic mechanisms, however, do not seem to be affected
as an acute response. In a study using both hippocampal slices from
rats of both sexes and an in vivo cat cervaux isole model using
female cats [18] we could not detect any acute effect of 17b
estradiol on synaptic activation or seizure generation. Also, more
speciﬁc investigations of possible effects on GABA responses using
iontophoretically applied GABA, before and after estrogen perfu-
sion, did not identify any change. This is in line with other studies
that have not shown any effect of estradiol on GABA-ergic
inhibition in Purkinje cerebellar cells [15]. However, all these
experiments were done with non-epileptic tissue that was
supposed to have intact inhibitory mechanisms. Nevertheless,
the ﬁndings agree with the early reports [5,7] in which
spontaneous cortical electrical activity in healthy animals was
found to be unchanged after i.v. injections of estrogens. In order to
produce epileptogenic activity, the estrogenic substance, Premarin,
had to be given to animals with both an epileptic focus and a focal
lesion of the blood–brain barrier. Therefore, it is possible that
patients with focal epilepsy might be much more susceptible to
changes in brain estradiol levels than healthy controls.
Estrogens also affect the GABA-ergic system over time. In a
series of studies by Woolley [14] it was shown that longer exposure
(greater than 24 h) to estradiol leads to suppressed GABA-ergic
inhibition of hippocampal neurons that may be related to
decreased GABA release at inhibitory synapses. In addition, it is
assumed that estradiol decreases GABA synthesis by reducing the
activity of glutamate decarboxylase (GAD) in the amygdala [19]
and in the substantia nigra [20,21]. However, these results were
not supported in a larger study by O’Connor et al. [22], where
changes in GAD activity in the cortex, hippocampus, and substantia
nigra were not detected.
Estradiol has also been found to alter brain morphology by
increasing dendritic spine density via an NMDA receptor-
dependent mechanism, and altering the pattern of hippocampalFig. 4. Changes in electroshock seizure thresholds after i.v. injections of 3a-5a-THP (
represent injections periods. Open circles represent stimulation trials that were subthresh
increase after both 3a-5a-THP and progesterone, but also the difference in time cou
progesterone.
Published with permission from: Taubøll E, Lindstro¨m S. The effect of progesterone and it
cortex in vivo. Epilepsy Res 1993;14:17–30.synaptic connectivity [17,23–25]. Estradiol selectively increased
neuronal sensitivity to synaptic input mediated by the NMDA type
of glutamate receptor, while responses mediated by the AMPA
receptor were not affected. Ovariectomy caused spine density to
decrease. These continuous, plastic changes in morphology, which
are related to spine density and neuronal sensitivity to glutamate
are probably of utmost importance for the effects of estrogen on
brain excitability.
One last point regarding the effect of estradiol, is the possibility
of regional differences. In the 1960s, Timiras and coworkers [26]
found that estradiol decreased seizure threshold in the dorsal
hippocampus and the medial amygdala, but simultaneously
increased seizure threshold in the lateral amygdala. Furthermore,
in rat medial amygdala brain slices, estradiol hyperpolarized 19 of
70 neurons from ovariectomized females. However, this effect was
highly regional as no effect was observed in 36 neurons of the
basolateral amygdala [27].
4. Progesterone
The mechanisms by which progesterone and its metabolites
exert their effects on brain excitability are, as for estrogens, also
through both classical and non-classical mechanisms, with the
latter being by far the most important. Progesterone receptors are
widely distributed in the brain [28] and progesterone circulating
in the blood gains rapid and relatively unrestricted access to all
parts of the nervous system [29,30]. Furthermore, neural tissue
and pituitary contain the enzyme 5a-reductase, which is able to
convert progesterone to 3a-5a-THP within the brain [31].
Production of this very effective anticonvulsant neurosteroid
can therefore take place in many regions of the brain. The
antiepileptic effect of progesterone is mainly attributed to its
conversion to 3a-5a-THP. Therefore, the anticonvulsant effect of
progesterone in the brain in in vivo models is somewhat delayed
in comparison with the immediate effect of its metabolite 3a-5a-
THP (Fig. 4).=3a-OH-DHP) (A), progesterone (B) and the solvent Glycofurol (C). Vertical bars
old for seizure initiation, ﬁlled circles trials followed by seizures. Note the threshold
rse with an immediate effect after 3a-5a-THP with a more delayed effect after
s metabolite 5a-pregnan-3a-ol-20-one on focal epileptic seizures in the cat’s visual
E. Taubøll et al. / Seizure 28 (2015) 3–11 7The main effect of 3a-5a-THP is related to an enhanced
postsynaptic GABA-ergic effect, as based on several lines of
evidence. 3a-5a-THP increases the inward chloride current
induced by GABA [32,33], increases the binding of muscimol
[33,34], stimulates the binding of ﬂunitrazepam [35], and displace
TBPS binding to the GABA receptor complex [35,36]. The effects of
3a-5a-THP on GABA-ergic inhibition were elegantly shown by
Majewska et al. in their Science paper from 1986 [32] that
demonstrated how the metabolite signiﬁcantly and dose-depen-
dently increased both the peak amplitude and duration of the
inward chloride current induced by GABA [32]. In line with this, we
were also able to demonstrate the effect both of progesterone, and
especially its metabolite, 3a-5a-THP, on recurrent GABA-ergic
inhibition in rat hippocampal slices [37].
How the effect on GABA-ergic induced chloride inﬂux is exerted
and exactly where the steroid binds to the GABA receptor complex
has been discussed. With regard to the effect on chloride inﬂux, it
was shown early on that this was mainly related to an increase in
the effective open-time of the chloride channels, as is also the case
for barbiturates [38]. Although this may be the most important
mechanism, later studies have shown a possible effect on opening
frequency also [39].
The binding site for progesterone metabolites differs from that
of both barbiturates and benzodiazepines. With regard to the
barbiturate site, it has been shown that 3a-5a-THP and
barbiturates both potentiate each other in their ability to
accelerate the dissociation of TBPS [40] and synergistic effects of
progesterone metabolites and barbiturates have been found in
chloride ﬂux studies in rat hippocampal slices [41]. Further, 3a-
5a-THP and secobarbitone exerted additive effects on muscimol
binding in all combinations of concentrations tested [33]. Thus,
steroid metabolites and barbiturates do not seem to share the same
site on the GABA receptor. With regard to the benzodiazepine
receptor, several lines of evidence demonstrate that steroid
metabolites do not act via an interaction with the benzodiazepine
recognition site [42,43]. For instance, while benzodiazepines
mainly affect chloride channels by increasing opening frequency
[44], steroids also increase open time [38,44]. There is therefore a
unique binding site for neurosteroids within the GABA-A receptorFig. 5. The amplitude of the monosynaptic component of the ﬁeld excitatory potential in 
the amplitude of the incoming nerve volley.
Data from Taubøll E, Lindstro¨m S. The effect of progesterone and its metabolite 5a-pregna
Res 1993;14:17–30 (ﬁgure not previously published).complex that is not directly related to either the barbiturate site or
the benzodiazepine site.
In addition to these postsynaptic GABA-ergic effects, which are
deﬁnitely the most important, there has been some discussion on
whether there could also be an additional presynaptic effect. Our in
vivo studies in the cat cervau isole´ preparation suggested that 3a-
5a-THP might also exert some presynaptic effects [45], as both the
monosynaptic and disynaptic components of the uninhibited
excitatory ﬁeld potential were reduced. This mimics the effect of
barbiturates in the same system, which, in addition to an effect on
postsynaptic inhibition, also acts presynaptically, by reducing the
transmitter release. In a study of monosynaptic excitatory
transmission in the spinal cord, the barbiturate-reduced transmit-
ter release was associated with a small decrease in the presynaptic
nerve volley [46]. A similar decrease in nerve volley was found
after both 3a-5a-THP and progesterone in our study [45]. An effect
on transmitter release is also indicated in Fig. 5, where the
amplitude of the monosynaptic component of the ﬁeld excitatory
potential in the dorsal lateral geniculate nucleus was plotted
against stimulus current or against the amplitude of the incoming
nerve volley (Fig. 5). The slope decreased after exposure to 3a-5a-
THP. The most likely explanation for this ﬁnding is a change in
transmitter release. A possible presynaptic additional effect also
gains some support from our study showing reduced GABA and
glutamate release from nerve terminals in rat hippocampus,
although concentrations were above clinical levels [47]. The
clinical relevance of a possible presynaptic effect is, however,
uncertain.
In addition to an effect on GABA responses, progesterone and its
metabolites may also affect excitatory mechanisms. In a series of
studies utilizing Purkinje cells from rat cerebellum, it was shown
that both progesterone itself and several of its metabolites,
including 3a-5a-THP, decreased glutamate responsiveness after
either systemic or topical application [48–50]. Further, progester-
one metabolites like 3a-5a-THP act at the NMDA receptor,
affecting at least sexual behavior, but probably also brain
excitability [51,52].
Little is known regarding the ability of progesterone metab-
olites to affect neuronal morphology directly, as has beenthe dorsal Lateral Geniculate Nucleus in the cat plotted against stimulus current and
n-3a-ol-20-one on focal epileptic seizures in the cat’s visual cortex in vivo. Epilepsy
Fig. 6. Average number of seizures after pentylenetetrazol in ovariectomized rats
administered vehicle, progesterone, RU5020, 3a-5a-THP, progesterone +RU486,
RU5020 + RU486, 3a-5a-THP + RU486 or RU486. See text for discussion.
Published with permission from: Frye CA, Rhodes ME. Female sex steroids and
neuronal excitability. In: Schwartzkroin PA, editor. Encyclopedia of basic epilepsy
research. UK: Academic Press/Elsevier; 2009. p. 477–84.
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found that chronic progesterone treatment of adult male rats
resulted in a 30% increase in the density of central benzodiazepine
receptors in the cerebral cortex, but not in the hippocampus [53].
Another way of affecting seizure susceptibility is by altering the
subunit composition of the GABA-A receptor. This may be of
importance for catamenial epilepsy and for its treatment. The most
striking ﬁnding following progesterone withdrawal, a model for
catamenial epilepsy, is the marked up-regulation of the alfa-4
subunit of the GABA receptor [9,54–57]. This subunit is insensitive
to benzodiazepines. The increase in alfa-4 expression also leads to
a decrease in inhibition gated by the GABA-A receptor [17]. By
dynamically changing GABA receptor subunit composition in
situations with progesterone withdrawal, which is the case
premenstrually, seizure threshold and sensitivity to AED treatment
will also vary on a cyclic basis. This can then contribute to the
phenomenon of catamenial epilepsy. In this context, it is of interest
that at least some neurosteroids may be able to modulate all
isoforms of GABA-A receptors, including those containing the alfa-
4 subunit. This provides possibilities for a new drug such as
Ganaxalone, for speciﬁc treatment of women with catamenial
epilepsy; Ganaxalone is, in essence, a neurosteroid, but also acts at
the alfa-4 subunit.
Although the effects on non-classical mechanisms are by far the
most important for the role of progesterone and its metabolites as
anticonvulsants, a possible effect on intracellular, classical
progesterone receptors cannot be completely excluded. In a series
of experiments, mainly on PTZ-induced seizures in ovariectomized
rats, a possible role for classical progesterone receptors as being
relevant for the anticonvulsant effect was demonstrated [13]. It
was shown that both progesterone, which acts both at the
intracellular level and after conversion to its metabolites at
the membrane receptor, and RU5020, which only acts at the
intracellular progesterone receptor, both markedly reduce tonic-
clonic seizures. When progesterone and especially RU5020 were
co-administered with RU38486, which blocks the intracellular
progesterone receptor, the anticonvulsant effect of the drugs was
considerably reduced (Fig. 6). These experiments suggest that
intracellular progesterone receptors may also be involved, at least
to some degree, in the anticonvulsant effect of progesterone and its
metabolites.
5. Androgens-mechanisms
The effects of androgens are mainly anticonvulsant, but the
opposite can also be the case. The variable actions of testosterone
may be partly due to the metabolism of testosterone. Testosterone
can be metabolized to 17b-estradiol, which is generally excitatory,
but also to androstandediol and dihydrotestosterone, which exert
potent antiepileptic effects [11].
As with the other sex steroids, androgens act via both classical
and non-classical mechanisms. The effect on classical mechanisms
is demonstrated by the proconvulsant effect of ﬂutamide, an
antagonist of the intracellular androgen receptor. In addition, it has
been shown that testicular feminized mice, which are totally
insensitive to androgens due to mutations in the intracellular
androgen receptor, do not exhibit the antiseizure effects of
androgens produced in wild-type animals [11].
Androgens clearly also act at non-classical, membrane recep-
tors [58,59]. Several of the androgen metabolites act as powerful
and positive modulators of the GABA-A receptor. For instance,
Reddy and Jian [59] showed that androstanediol produced a
concentration-dependent enhancement of GABA-activated cur-
rents. At 1 mM, androstanediol produced a 50% potentiation of
GABA responses. In the absence of GABA, androstanediol had
moderate direct effects on GABA-A receptor-mediated currents athigh concentrations. Systemic doses of androstanediol (5–100 mg/
kg), but not its 3b-variant, caused dose-dependent suppression of
behavioral and electrographic seizures in a mouse hippocampal
kindling model, which is a model of temporal lobe epilepsy. At high
doses, androstanediol produced complete seizure protection that
lasted for up to 3 h after injection.
Androgens also have effects on neuronal structure and function.
Testosterone application to gonadectomized male rats increases
the number of spine synapses in the stratum radiatum of area CA1
in the hippocampus [60]. Androgens may also affect spine synapse
density in the hippocampus in female rats and contribute to plastic
changes over the course of the menstrual cycle [61]. The
importance for epilepsy of these ﬁndings of altered morphology
with regard to the androgens is still uncertain.
6. The effects of epilepsy on endocrine function
Reproductive dysfunction and endocrine disorders are common
among both men and women with epilepsy, indicating an effect of
the epilepsy itself. In women, menstrual disorders, polycystic
ovaries, hypothalamic amenorrhea, premature menopause, and
reduced fertility have been described, while in men reduced
potency and sperm abnormalities have been found [62–64]. In
both sexes, sexual problems like diminished sexual desire, reduced
sexual responsiveness, orgasmic dysfunctions, as well as reduced
E. Taubøll et al. / Seizure 28 (2015) 3–11 9genital blood ﬂow in women and ejaculation disorders in men have
been described [65–67].
The reasons for the changes in reproductive endocrine function
are, however, multifactorial. They include psychosocial factors, co-
morbidity, the use of AEDs, and, ﬁnally, the epilepsy itself.
Clinically, it is difﬁcult to distinguish the direct effect of
epileptic activity, independent of the many confounding factors
mentioned above. But results from clinical studies provide
indications of a direct effect of epilepsy on reproductive endocrine
function. For instance, a greater occurrence of sexual dysfunction
has been found in both men and women with right-sided, versus
left-sided, temporal epilepsy [68], with sexual interest primarily
decreased. Prolactin responses may also reach higher levels in
right-sided versus left-sided epileptiform discharges [69]. Higher
prolactin levels may also contribute to reduced libido and erectile
difﬁculties [70]. In women, it has been found that anovulatory
cycles are more common with right-sided amygdalectomies than
left-sided ones [71]. Finally, studies by Herzog and coworkers have
shown that there is laterality in reproductive endocrine function
and disorders in women with epilepsy [62,72,73]. Left temporal
lobe epilepsy was associated with signiﬁcantly higher pulse
frequency of gonadotropin-releasing hormone (GnRH) secretion
[73], which, in turn, is associated with higher luteinizing hormone/
follicle-stimulating hormone (LH/FSH) ratios and higher testoster-
one levels. This eventually leads to polycystic ovaries, which are
found more frequently after left-sided epileptic epilepsy than
right-sided epileptic epilepsy. On the other hand, right temporal
foci have a reduced GnRH pulse frequency, lower LH and estradiol
levels, and a higher frequency of hypothalamic amenorrhea
[62,73,74]. Such lateralized effects can hardly be attributed to
confounding factors like the inﬂuence of AEDs, and thus indicate aFig. 7. Photomicrographs of hypothalamic nuclei from one right-amygdala-stimulated rat
preoptic area (MPA) and paraventricular hypothalamic nucleus (PVH), areas not involved
predominating numbers of Fos-ir neurons in the medial preoptic nucleus (MPO), ventr
premamillary nucleus (PMV), areas that are involved in reproductive function and rep
Published with permission from: Silveira DC, Klein P, Ransil BJ, Liu Z, Hori A, Holmes GL
neurons with unilateral amygdaloid seizures. Epilepsia 2000;41:34–41.direct effect of the epilepsy itself on reproductive endocrine
function.
In men with temporal epilepsy the pulsatile secretion of LH has
been found to be disturbed [75]. Interictally, both circadian and
ultradian rhythms were altered with a generally delayed LH peak.
Postictally, there was a random dispersal of the timing of the LH
peak and prolongation of interburst intervals. The material
consisted of only ten patients, seven with left-sided focus and
three with right. However, despite the small number of patients, it
is interesting that right temporal seizures were associated with LH
concentration phase delays and left temporal seizures with
advances. Again, such lateralized effects are probably due to the
epilepsy itself, not to concomitant medication.
With regard to reproductive endocrine disorders related to
different types of epilepsy, there is no convincing evidence that
such problems are more common in partial or generalized
epilepsies. Some studies have indicated more reproductive and
sexual problems in patients with partial epilepsy [76–78], while
others found that this could be more common in women with
idiopathic generalized epilepsy [79–81]. Thus we are currently
unable to reach ﬁrm conclusions regarding associations between
epilepsy type and reproductive endocrine problems.
Some of the problems related to clinical studies can be
overcome by the use of animal models. Very close anatomical
connections between the temporolimbic system and the hypo-
thalamus, which is controlling the neuroendocrine system
including both the hypothalamic–pituitary–gonadal and the
hypothalamic–pituitary–adrenal axis, have been demonstrated.
The amygdala in particular, has massive direct reciprocal connec-
tions with regions of the hypothalamus that are involved in the
regulation, production, and secretion of GnRH. In line with this,. (A and C) Similar numbers of Fos-ir neurons on the left and right sides of the medial
 in reproductive endocrine function. (B, D and E) Laterally asymmetric, ipsilaterally
olateral part of the ventromedial hypothalamic nucleus (VMH), and in the ventral
roductive endocrine secretion.
, LaCalle S, Elmquist J, Herzog AG. Lateral asymmetry in activation of hypothalamic
E. Taubøll et al. / Seizure 28 (2015) 3–1110early studies demonstrated how amygdala kindling in male cats
led to hyposexuality [82] and limbic seizures elicited in female rats
led to interruption of the estrous cycle and divergent mating
behavior [83]. Stimulation of the corticomedial amygdala can
induce ovulation and uterine contractions in several species
[84,85]. Bilateral amygdalectomy in adult male rats and cats has
been found to result in marked degeneration of the testes [86], and
bilateral ablations of the basolateral portion of the amygdala in
adult female deer mice can induce anovulatory cycles and
polycystic ovaries [87]. Further, bilateral amygdalectomy in female
monkeys induces amenorrhea and hypogonadal vaginal changes
[88]. These studies demonstrate the close interactions between
neuronal hyperactivity or hypoactivity in the temporolimbic brain
areas and reproductive endocrine function.
Somewhat later, Edwards and co-workers [89,90] showed how
seizures affected reproductive function in both female and male
rats. In females, amygdala-kindled seizures arrested ovarian
cyclicity. The animals also had high serum estradiol, increased
pituitary weight, and polyfollicular ovaries. Progesterone treat-
ment to kindled females restored cyclicity in only ﬁve of 28 (18%)
of the animals that had stopped cycling, while all sham-kindled
(n = 5) controls that had stopped cycling regained cyclicity. In male
rats, amygdala-kindled seizures resulted in an increase in serum
testosterone, estradiol, and prolactin in intact males, accompanied
by a signiﬁcant increase in testis, epididymis, and pituitary weight,
as well as a signiﬁcant decrease in prostate weight. Maximal
electroshock seizures caused a short-term reduction in serum
testosterone and testis, epididymis, and prostate weight. This
indicates that both focal limbic (amygdaloid) seizures and
generalized maximal electroshock seizures disturb normal repro-
ductive physiology in the male rat.
In an elegant study, Silveira and co-workers [91] showed
asymmetric activation of hypothalamic regions after unilateral
amygdala-stimulated seizures. Studying Fos-immunoreactivity in
different hypothalamic areas, they found that three areas that are
prominently involved in reproductive function, the medial preoptic
nucleus (MPO), the ventrolateral part of the ventromedial hypo-
thalamus (VMHVL), and the ventral premammillary nucleus (PMV).
These areas showed both signiﬁcantly greater and more asymmet-
ric, ipsilaterally predominating induction of Fos after unilateral
amygdala-stimulated seizures than other regions that were
investigated, such as sexually undifferentiated regions like the
lateral (LPO), medial preoptic area (MPA), the dorsomedial portion of
the ventromedial nucleus (VMHDM), and the paraventricular
nucleus (PVH), which are involved in other endocrine functions
(Fig. 7). Asymmetric activation of the hypothalamus could be the
basis for the occurrence of different reproductive endocrine
disorders for patients with left-sided or right-sided temporal lobe
epilepsy, since the hypothalamus has a clear asymmetry in its
reproductive function, including asymmetric content of GnRH [92].
These studies clearly demonstrate a direct effect of epilepsy and
epileptic discharges on reproductive endocrine function.
In conclusion, there is a close interaction between sex steroid
hormones and epilepsy. Sex steroid hormones play an important
role in neuronal excitability and seizure susceptibility with
progesterone and its metabolites being anticonvulsive, with
estrogens being mainly proconvulsive. The monthly ﬂuctuations
in progesterone and estrogen are thought to be the basis for
catamenial epilepsy. Androgens have more varied effects, although
considered mainly anticonvulsive. Epilepsy itself, especially
through temporolimbic connections, affects the secretion of
pituitary hormones thereby affecting secretion pattern, rhythmic-
ity and hormone levels of the peripheral sex steroid hormones.
Even laterality of epileptic activity are of importance as there has
been shown different endocrine disturbances in patients with left-
sided compared to right sided epileptic foci.Conﬂict of interest statement
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